Voyager Therapeutics, Inc.

NASDAQ:VYGR

Biotechnology

Healthcare
$1.67 +2.35%

+$0.09 today

Market cap
$103.92M
Beta
1.25
P/E (TTM)
-1.9
EPS (TTM)
-$1.96
52W Low $2.83High $5.55

Volume 0.84M

Average 0.54M

Balance Sheet

Inspect the capital base behind the business.

Assets

$252.28M

FY 2025 · Annual

-35.8% YoY

Liabilities

$56.20M

FY 2025 · Annual

-39.8% YoY

Equity

$196.08M

FY 2025 · Annual

-34.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents117.43M98.96M68.8M71.37M65.3M
Short-term Investments15.11M19.89M162.07M195.32M131.15M
Net Receivables748K639K84.46M4.49M1.76M
Inventory00000
Other Current Assets1.7M4.23M2.63M2.87M4.48M
Total Current Assets136.7M124.5M319.68M276.81M202.69M
Property, Plant & Equipment (Net)55.38M33.34M30M47.66M41.61M
Goodwill00000
Intangible Assets00000
Long-term Investments00065.7M0
Tax Assets00000
Other Non-current Assets1.78M1.52M1.59M2.87M7.98M
Total Non-current Assets57.16M34.86M31.6M116.24M49.59M
Total Assets193.86M159.36M351.28M393.05M252.28M
Account Payables574K2.57M1.6M4M5.01M
Short-term Debt00000
Tax Payables00000
Deferred Revenue33.89M59.38M42.88M24.39M1.59M
Other Current Liabilities5.02M4.56M6.61M6.75M9.09M
Total Current Liabilities50.98M72.59M64.51M49.79M26.54M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)8.21M6.45M32.36M6M0
Other Non-current Liabilities1M1M1M1M1M
Total Non-current Liabilities47.82M27.75M50.45M43.5M29.66M
Total Liabilities98.8M100.34M114.96M93.29M56.2M
Common Stock38K38K44K55K59K
Retained Earnings(347.1M)(393.51M)(261.18M)(326.18M)(445.91M)
Accumulated OCI(138K)(219K)(48K)(407K)32K
Other Stockholders Equity00000
Minority Interest00000
Total Equity95.06M59.02M236.32M299.76M196.08M
Total Debt44.18M23.13M20.29M43.73M36.5M
Net Debt(73.25M)(75.83M)(48.51M)(27.64M)(28.8M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$43.3M
Short-term Investments$98.2M
Receivables$1.6M
Other Current$3.9M
Total Current Assets$147.0M
PP&E (Net)$39.4M
Other Non-current$32.9M
Total Non-current Assets$72.3M
Total Assets$219.3M

Analysis

Selected assets total $219.3M for Latest. The largest visible component is Short-term Investments at $98.2M, about 44.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
8-KCurrent reportOct 21, 2026

How much cash does VYGR have?

Voyager Therapeutics, Inc. (VYGR) reported $65.30M in cash and equivalents in fiscal 2025.

How much debt does VYGR carry?

Voyager Therapeutics, Inc. (VYGR) reported $36.50M of total debt, with net debt of -$28.80M.